AUS
NZ
UK
CA
USA
IND
Healt
Tryptamine Therapeutics advances psilocin study for Binge Eating Disorder Asx 300
August 07, 2025 05:08 PM AEST| By Team Kalkine MediaHighlights,Clinical trial investigates intravenous psilocin therapy for Binge Eating Disorder,Permit secured by Swinburne University for research on controlled substances,Dosing scheduled to begin this quarter following patient screening and supply l...
Understanding the Value of ResMed CDI (ASX:RMD) in 2025
August 07, 2025 12:47 PM AEST| By Team Kalkine MediaHighlights,Focus on ResMed CDI's dual business segments,Financial and operational trends covered,Overview of valuation and market standing,ResMed CDI (ASX:RMD) continues to draw attention among investors in 2025, being part of the,ASX 200 companies,....
Tryptamine Therapeutics Set to Begin Groundbreaking Psilocin Trial for Binge Eating Disorder
August 07, 2025 11:25 AM AEST| By Team Kalkine MediaHighlights,Dosing to start soon for TRP-8803 in clinical study,Focus on safety and therapeutic effects for BED,Study supported by formal regulatory approval,Tryptamine Therapeutics Ltd (ASX:TYP) is progressing with a clinical study evaluating intrave...
Percheron unveils promising data for potential triple-negative breast cancer treatment
August 06, 2025 04:17 PM AEST| By Team Kalkine MediaHighlights,New preclinical findings highlight a treatment prospect targeting VISTA in triple-negative breast cancer,Preclinical results suggest HMBD-002 may suppress tumour growth by modulating immune and growth pathways,Therapeutic potential expands...
ASX SHL Shares: Exploring the Role of Sonic Healthcare in the ASX 100
August 06, 2025 03:52 PM AEST| By Team Kalkine MediaHighlights,Global presence with diversified medical services,Consistent demand in healthcare sector,Ethical and sustainable business appeal,Sonic Healthcare (ASX:SHL) holds a notable position among the,top ASX 100,companies, making it an influential...
Biotech Developments Spotlight Emerging Healthcare Innovators
August 06, 2025 03:37 PM AEST| By Team Kalkine MediaHighlights,Healthcare sector rotation sparks renewed interest in innovation-led biotech companies,Summit Biotech Fund backs advanced therapies targeting cancer, mental health, and immune diseases,ASX-listed life science firms explore scalable treatme...
New Preclinical Insights into HMBD-002 for Triple-Negative Breast Cancer
August 06, 2025 10:27 AM AEST| By Team Kalkine MediaHighlights,New lab results unveiled for HMBD‑002 in TNBC,Focus on VISTA as an immune system target,Broader research underway for multiple cancers,Percheron Therapeutics Ltd (ASX:PER) has shared new laboratory results on its investigational therapy HM...
Telix Pharmaceuticals Experiences Momentum Amid Regulatory Hurdles
August 05, 2025 04:41 PM AEST| By Team Kalkine MediaHighlights,Telix Pharmaceuticals (ASX:TLX) continues to gain traction despite regulatory uncertainties,Recent global product approvals boost commercial prospects for the company,Pipeline progress and reimbursement milestones provide strategic leverag...
Recce Pharmaceuticals Showcases Biodefence Advances at Leading US Military Health Symposium
August 05, 2025 04:24 PM AEST| By Team Kalkine MediaHighlights,Recce to present data on synthetic anti-infective R327,Findings address high-priority bioterrorism pathogens,Focus on military and public health readiness,Recce Pharmaceuticals Ltd (ASX:RCE) is set to present new research on its lead synth...
Sonic Healthcare and Xero: A Look at Two Notable ASX 100 Stocks in 2025
August 05, 2025 03:05 PM AEST| By Team Kalkine MediaHighlights,Global healthcare leader with expanding services,Cloud accounting innovator supporting small businesses,Valuation trends offer useful market insight,A Broader Look at Sonic Healthcare (ASX:SHL),Sonic Healthcare is a well‑established global...
CSL Ltd in the Spotlight: Valuing an ASX 100 Healthcare Leader
August 04, 2025 08:47 PM AEST| By Team Kalkine MediaHighlights,Overview of CSL's core operations,Key factors influencing valuation,Insights into financial health,CSL Ltd (ASX:CSL), part of the,ASX 100 stocks,, is a global biotechnology leader with a diverse portfolio focused on saving lives and improv...
Azer-cel Shows Strong Progress in Blood Cancer Treatment: Insights from Imugene (ASX:IMU)
August 04, 2025 04:49 PM AEST| By Team Kalkine MediaHighlights,Breakthrough results from Phase 1b trial of azer-cel,Durable cancer remission observed in multiple patients,Next step: pivotal registration study discussions with FDA,Imugene (ASX:IMU) has shared encouraging updates from its Phase 1b clini...
Novonix Withdraws Spin-Out Strategy Amid Graphite Market Caution
August 04, 2025 03:15 PM AEST| By Team Kalkine MediaHighlights,Spin-out strategy involving graphite assets has been withdrawn,Market dynamics influenced deal cancellation,Focus shifts to re-evaluating strategic progress,asx 200,index participants continue to navigate evolving market environments, with...
Imugene’s Azer-cel Therapy Shows Encouraging Progress in Phase 1b Trial
August 04, 2025 02:28 PM AEST| By Team Kalkine MediaHighlights,Azer-cel therapy demonstrates strong clinical activity in blood cancer treatment,Expanded trial now includes wider range of lymphoma subtypes,First Australian patient shows complete cancer clearance,Imugene Ltd (ASX:IMU) has shared new cli...
Is Sonic Healthcare (ASX:SHL) Undervalued in 2025? | ASX 300 Healthcare Stock Deep Dive
August 02, 2025 04:50 PM AEST| By Team Kalkine MediaHighlights,Revenue trend shows consistency across core operations,Metrics reflect post-pandemic adjustments,Capital structure indicates balanced financial positioning,Sonic Healthcare is one of the most recognised names in the medical diagnostics fie...
Healthcare Momentum Builds with ImpediMed, SomnoMed & Clarity Pharmaceuticals
August 02, 2025 01:41 AM AEST| By Team Kalkine MediaHighlights,Healthcare sector shows signs of steady recovery,ImpediMed reports strong performance in the US,Clarity Pharmaceuticals secures major funding for clinical growth,Australia’s healthcare sector has emerged as one of the more active segments...
Imugene Advances Cancer Therapy Programs While Strengthening Capital Position
August 01, 2025 06:07 PM AEST| By Team Kalkine MediaHighlights,Clinical progress across multiple oncology trials,Strengthened funding to advance research pipeline,Expanded intellectual property portfolio,Imugene Ltd (ASX:IMU) has released its latest quarterly update, revealing meaningful advancements...
ResMed (ASX:RMD) Reports Strong FY25 Results Amid Rising Healthcare Demand | ASX 200 Healthcare
August 01, 2025 03:44 PM AEST| By Team Kalkine MediaHighlights,ResMed delivers robust FY25 results,Strong demand in sleep and digital health solutions,Operational efficiencies support margin growth,ResMed, a prominent player in respiratory and sleep health, has reported a strong finish to fiscal year...
Regis Healthcare rallies ahead of possible S&P/ASX 200 entry
August 01, 2025 03:23 PM AEST| By Team Kalkine MediaHighlights:,Regis Healthcare gains traction amid index reshuffle expectations,Recent executive share sale draws attention to company movement,Aged care sector experiences renewed market focus,Regis Healthcare (ASX:REG), a provider in the aged care se...
BlinkLab Limited (ASX:BB1) Nears a Key Milestone in Profitability Journey
August 01, 2025 02:50 PM AEST| By Team Kalkine MediaHighlights,Focus on smartphone-based neurobehavioral testing innovation,Analysts expect a shift towards profitability in the near future,Debt-free position supports operational flexibility,BlinkLab Limited (ASX:BB1) is a healthcare technology company...
Advertise your brand on Kalkine Media